Terms: = Germ cell tumor AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791 AND Treatment
5 results:
1. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
2. EZH2 as a mediator of treatment resistance in melanoma.
Tiffen JC; Gallagher SJ; Tseng HY; Filipp FV; Fazekas de St. Groth B; Hersey P
Pigment Cell Melanoma Res; 2016 Sep; 29(5):500-7. PubMed ID: 27063195
[TBL] [Abstract] [Full Text] [Related]
3. Molecular characteristics of liver metastases from uveal melanoma.
Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
[TBL] [Abstract] [Full Text] [Related]
4. Improvement of overall survival of patients with cutaneous melanoma in germany, 1976-2001: which factors contributed?
Lasithiotakis KG; Leiter U; Eigentler T; Breuninger H; Metzler G; Meier F; Garbe C
Cancer; 2007 Mar; 109(6):1174-82. PubMed ID: 17265520
[TBL] [Abstract] [Full Text] [Related]
5. Primary tumors of the mediastinum.
Whooley BP; Urschel JD; Antkowiak JG; Takita H
J Surg Oncol; 1999 Feb; 70(2):95-9. PubMed ID: 10084651
[TBL] [Abstract] [Full Text] [Related]
